Collegium Pharmaceutical (COLL) Acquisitions (2018 - 2022)
Collegium Pharmaceutical (COLL) posted Acquisitions of $572.1 million for Q1 2022, up 493062.93% on a QoQ basis from $116000.0 in Q2 2018.
Powered by 
Analysis
Collegium Pharmaceutical (COLL) Acquisitions (2018 - 2022) Analysis & Trends
Collegium Pharmaceutical has reported Acquisitions for 2 years, with the latest figure at $572.1 million in Q1 2022.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $572.1 million in Q1 2022; TTM through Dec 2022 was $572.1 million, a N/A change from a year earlier, with the FY2024 full-year figure at $267.5 million, changed N/A from the prior year.
- Acquisitions was $572.1 million for Q1 2022 at Collegium Pharmaceutical, up from $116000.0 in the prior quarter.
- The five-year high for Acquisitions was $572.1 million in Q1 2022, with the low at $116000.0 in Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | -17.24 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -23.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Collegium Pharmaceutical | 753.09 Mn | 603.77 Mn | 110.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 572.07 Mn |
| Jun 30, 2018 | 116,000.00 |
| Mar 31, 2018 | 18.76 Mn |